Showing results (31-40 of 101) with videos related to
Sort By:
Pageof 11
Cancer Research|March 27, 2015
Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent MechanismsStefan Klingler, Baofeng Guo, Jun Yao, et al.Cancer Letters|June 10, 2021
KRAS-dependent cancer cells promote survival by producing exosomes enriched in SurvivinWen-Hsuan Chang, Thuy-Tien Thi Nguyen, Chia-Hsin Hsu, et al.Science (New York, N.Y.)|September 18, 2007
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapiesJayne M Stommel, Alec C Kimmelman, Haoqiang Ying, et al.Cancer Research Communications|January 6, 2026
The Lysine Demethylase KDM4C is an Oncogenic Driver and Regulates ERK Activity in KRAS Mutant Pancreatic Ductal AdenocarcinomaMenna-T-Allah Shaheen, Sarah Dhebat, Kimal I Rajapakshe, et al.Toxicologic Pathology|November 3, 2005
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumorsNicolas Currier, Sandra E Solomon, Elizabeth G Demicco, et al.International Journal of Cancer|September 1, 2019
A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeuticsXinggang Wu, Mikyung Park, Dilara A Sarbassova, et al.Cancer Research|June 12, 2021
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK InhibitionLiang Yan, Bo Tu, Jun Yao, et al.Oncogene|October 2, 2019
Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancerKanchan Singh, Melissa A Pruski, Kishore Polireddy, et al.Nature Communications|December 7, 2021
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistanceYalan Deng, Xianghou Xia, Yang Zhao, et al.Genes & Development|March 17, 2011
Pancreatic cancers require autophagy for tumor growthShenghong Yang, Xiaoxu Wang, Gianmarco Contino, et al.Pageof 11